Cargando…
Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy
Evidence theory by Dempster-Shafer for determination of hormone receptor status in breast cancer samples was introduced in our previous paper. One major topic pointed out here is the link between pieces of evidence found from different origins. In this paper the challenge of selecting appropriate wa...
Autores principales: | Kenn, Michael, Karch, Rudolf, Singer, Christian F., Dorffner, Georg, Schreiner, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865003/ https://www.ncbi.nlm.nih.gov/pubmed/36675780 http://dx.doi.org/10.3390/jpm13010119 |
Ejemplares similares
-
Decision theory for precision therapy of breast cancer
por: Kenn, Michael, et al.
Publicado: (2021) -
Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer
por: Kenn, Michael, et al.
Publicado: (2022) -
Co-expressed genes enhance precision of receptor status identification in breast cancer patients
por: Kenn, Michael, et al.
Publicado: (2018) -
Clustering molecular dynamics conformations of the CC’-loop of the PD-1 immuno-checkpoint receptor
por: Schreiner, Wolfgang, et al.
Publicado: (2023) -
Conformational flexibility of a free and TCR-bound pMHC-I protein investigated by long-term molecular dynamics simulations
por: Tomasiak, Lisa, et al.
Publicado: (2022)